13 varieties were evaluated with consistent evaluation of sodium cephalosporine

Content source: Pharmaceutical Rubik's Cube Info December 25, the official website of the State Drug Administration shows 13 generic drugs through the consistent evaluation, among them, Zhejiang Huideson and Shandong Runze injection of cephalosporine sodium, Beijing Ted and Nanjing Jianyou's benzene shun aquku ammonium injection are the first simultaneous evaluation varieties.
sodium cephalosporine is the second generation of cephalosporins injected with cephalosporin, which is the second generation of cephalosporins in the broad spectrum, and its action is to inhibit the synthesis of bacterial cell walls by binding bacterial proteins.
by the pharmaceutical Rubik's Cube PharmaGo database, the current variety in addition to Zhejiang Hudison and Shandong Runze at the same time, there are 3 enterprises in the consistent evaluation and declaration stage.
according to the medical Rubik's Cube IPM data, injection of cephalosporine sodium in 2019 national sales of about 2.4 billion yuan.
benzene shun aquco ammonium injection benzene shun aquku ammonium injection as an auxiliary drug of whole hemp in the intensive care unit (ICU) to play a sedative role.
it relaxes skeletal muscles, making trachea intination and mechanical airfly easy to perform.
was developed by Aspen/GSK and later acquired by GlaxoWellcome and approved by the FDA in December 1995 for a product called Nimbex ®.
was awarded the U.S. market for Glaxo Wellcome narcotic drugs in November 1999, Abbott is currently responsible for the commercial sale of the variety in the United States.
June 2004, Nimbex ® was first approved for listing in China and currently has 3 sizes of 5mg/2.5ml, 10mg/5mL, 20mg/10ml.
, Nanjing Jianyou developed a total of 3 specifications of benzene shun aquku ammonium injection, including 10 mg/5 mL, 20 mg/10 mL, 200 mg/20 mL, all approved by the FDA in April 2019.
then transferred to the domestic declaration of listing, "the same production line production, has been listed in the United States, apply for domestic listing of generic drugs" reasons were included in the priority review.
approved is the 10 mg/5 mL specification and 20 mg/10 mL is in the "in approval" phase.
that since the original 200 mg/20 mL specification has not yet been listed in China, in May 2019, NMPA concluded that clinical approval had been made.
's Benzene Shun Aquku ammonium injection (10mg/5ml, 20 mg/10 mL) was approved by the FDA for listing in the United States in September 2017 and domestically in February 2018.
because the registration time is old 6 categories.
, Henri submitted a consistent evaluation application three months after its approval and is currently in the "in review" phase.
same time, as the 200 mg/20 mL specification of the original research has not yet been listed in China, so in October 2018 Hengrui new specifications according to the 3 categories of declared listing approval conclusions are also approved clinical.
by the pharmaceutical Rubik's Cube PharmaGo database, the current variety in addition to Beijing Ted and Nanjing Jianyou at the same time, there are 10 enterprises in the consistent evaluation and declaration stage.
according to the medical Rubik's Cube IPM data, the national sales of benzene shun aquku ammonium injection in 2019 is about 2.175 billion yuan.
yew alcohol injection yew alcohol is a natural anti-tumor drug developed from the trunk and bark of the sequoia plant yew.
the polymerized micro-tube protein is its target, hindering the formation of spindles and preventing the normal division of cells, thereby inhibiting tumor growth.
because of its small water solubility, injections are usually added to surfactants, such as poly-cyclooxidizing castor oil and other solvents, often causing vascular thusion, lower blood pressure and hypersensitivity reactions.
routine pre-treatment of glucoticoids and antihistamines is required.
by the Pharmaceutical Rubik's Cube PharmaGo database, in addition to Yangzijiang and Sichuan Huiyu evaluation, there are currently 2 enterprises in the declaration / same declaration consistency evaluation.
。